glp 1 and colon cancer Could GLP-1 medications help slow progression?⁣ ⁣ A new Cleveland Clinic study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to Diabetes and Colorectal Cancer Risk:

Anthocyanins can reduce the levels of inflammatory markers, including C-reactive protein (CRP), interleukin-1 (IL-1), and vascular cell adhesion molecule-1 (VCAM-1 or CD106) (Zhu et al

Molecules 19 (11), 1906619077

"Taking GLP-1s may be one of those decisions people need to discuss with their doctor, knowing that it requires a long-term commitment and may not be the best fit for those who struggle with taking medication daily or weekly." Copyright 2026 Nexstar Media, Inc

Because of cost-effective production, Indian companies remain competitive in global markets

Ketogenic diet uncovers differential metabolic plasticity of brain cells